Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Berg

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
British Journal of Clinical Pharmacology|September 18, 2012
Half-life prolongation of therapeutic proteins by conjugation to ATIII-binding pentasaccharides: a first-in-human study of CarboCarrier® insulinAndré M M Miltenburg, Marita Prohn, Jacqueline H M van Kuijk, et al.
Mutation Research|March 8, 2005
Dose-dependent effects of UVB-induced skin carcinogenesis in hairless p53 knockout miceHenk J van Kranen, Anja Westerman, Rob J W Berg, et al.
National Cancer Institute Monograph|June 1, 1981
Cancer incidence and mortality in the United States, 1973-77J L Young, C L Percy, A J Asire, et al.
British Journal of Pharmacology|October 22, 2011
Mechanism of action of a nanomolar potent, allosteric antagonist of the thyroid-stimulating hormone receptorChris J van Koppen, Marcel E de Gooyer, Willem-Jan Karstens, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
British Journal of Clinical Pharmacology|September 18, 2012
Half-life prolongation of therapeutic proteins by conjugation to ATIII-binding pentasaccharides: a first-in-human study of CarboCarrier® insulinAndré M M Miltenburg, Marita Prohn, Jacqueline H M van Kuijk, et al.
Mutation Research|March 8, 2005
Dose-dependent effects of UVB-induced skin carcinogenesis in hairless p53 knockout miceHenk J van Kranen, Anja Westerman, Rob J W Berg, et al.
National Cancer Institute Monograph|June 1, 1981
Cancer incidence and mortality in the United States, 1973-77J L Young, C L Percy, A J Asire, et al.
British Journal of Pharmacology|October 22, 2011
Mechanism of action of a nanomolar potent, allosteric antagonist of the thyroid-stimulating hormone receptorChris J van Koppen, Marcel E de Gooyer, Willem-Jan Karstens, et al.
Pageof 7